Translate this page into:
Commentary
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
The authors presented two rare cases of scalp malignant nodular hidradenoma (MNH).[1] Both tumors recurred in spite of total excision and radiotherapy. The preferred treatment is an early wide surgical excision of the tumor. Recently, innovation of radiation delivery technique enabled IMRT (intensity modulated radiation therapy) for complex-shaped targets.[2] VMAT (volumetric modulated arc therapy) or Rapid Arc[3] therapy and helical tomotherapy[4] give a high dose to widely spread scalp and skull tumors, sparing the underlying brain parenchyma as much as possible. IMRT as well as chemotherapy including the molecular targeting therapy is to be evaluated for adjuvant therapy after the surgical resection or for salvage therapy in case of recurrence.
References
- Total scalp radiation using image-guided IMRT for progressive cutaneous T cell lymphoma. Br J Radiol. 2009;82:e122-5.
- [Google Scholar]
- Total dural irradiation: RapidArc versus static-field IMRT: A case study. Med Dosim. 2012;37:175-81.
- [Google Scholar]
- Brain-sparing holo-cranial radiotherapy: A unique application of helical tomotherapy. Clin Oncol (R Coll Radiol). 2011;23:86-94.
- [Google Scholar]
